pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
umitrelimorgene autodencel
umitrelimorgene autodencel [INN]
Glioblastoma Multiforme (GBM)
Immunomic Therapeutics Inc
0 catalysts
Phase 2
unasnemab
Traumatic Spinal Cord Injury
Repulsive guidance molecule A
Tanabe Pharma Corp
0 catalysts
Phase 3
upacicalcet sodium
Secondary Hyperparathyroidism
Pathalys Pharma Inc
0 catalysts
← prev
page 266 of 271
next →
131
Pain89
Neurology1
Phase 2
urcosimod
Keratoconjunctivitis Sicca (Dry Eye)
$OKYOOKYO Pharma Ltd
0 catalysts
Marketed
uridine triacetate
Xuriden (uridine triacetate)
Mitochondrial Diseases
BTG International Inc
0 catalysts
Marketed
urofollitropin
Bravelle (urofollitropin)
Anovulation
Ferring Pharmaceuticals Inc
0 catalysts
Phase 1
usmarapride
usmarapride [INN]
Alzheimer's Disease
Suven Life Sciences Ltd
0 catalysts
Phase 2
usnoflast
Amyotrophic Lateral Sclerosis
Zydus Lifesciences Ltd
0 catalysts
Phase 2
utenpanium chloride
Obesity
Raziel Therapeutics
0 catalysts
Phase 2
utidelone
utidelone [INN]
Breast Cancer
BioStar Pharmaceuticals Inc
0 catalysts
Phase 2
uzatresgene autoleucel
Ovarian Cancer
US WorldMeds LLC
0 catalysts
Phase 2
vabametkib
vabametkib [INN]
Non-Small Cell Lung Cancer
Abion Inc
0 catalysts
Phase 3
vactosertib
vactosertib [INN]
Metastatic Colorectal Cancer
MedPacto Inc
0 catalysts
Phase 2
vadernersen sodium
X Chromosome Disorders
$IONSIONIS PHARMACEUTICALS INC
0 catalysts
Phase 2
vafidemstat
vafidemstat [INN]
Borderline Personality Disorder (BPD)
Oryzon Genomics SA
0 catalysts
Marketed
valbenazine
Valbenazine (valbenazine)
Tardive Dyskinesia
Lupin Ltd
0 catalysts
Phase 2
valemetostat
valemetostat [INN]
Non-Small Cell Lung Cancer
Daiichi Sankyo Co Ltd
0 catalysts
Phase 1
valiloxybate ER
valiloxybate
Narcolepsy
$ALKSAlkermes plc.
0 catalysts
Phase 3
valiltramiprosate
Alzheimer's Disease
Amyloid-beta precursor protein
Alzheon Inc
0 catalysts
Marketed
valoctocogene roxaparvovec
Roctavian (valoctocogene roxaparvovec)
Hemophilia A (Factor VIII Deficiency)
$BMRNBIOMARIN PHARMACEUTICAL INC
0 catalysts
Marketed
valrubicin
Valstar (valrubicin)
Bladder Carcinoma
Endo Pharmaceuticals Inc
0 catalysts
Marketed
valsartan
Valsartan (valsartan)
Cardiovascular Risk Factors
Square Pharmaceuticals PLC
0 catalysts
Phase 3
vamikibart
Panuveitis
F. Hoffmann-La Roche Ltd
0 catalysts
Marketed
vamorolone
Agamree (vamorolone)
Becker Muscular Dystrophy
Glucocorticoid receptorMineralocorticoid receptor
ReveraGen BioPharma Inc
0 catalysts
Phase 2
vamotinib
vamotinib [INN]
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Fusion Pharmaceuticals Inc
0 catalysts
Marketed
vancocin hydrochloride
Vancomycin Hydrochloride Ani (vancomycin hydrochloride)
Enterocolitis
$ANIPANI PHARMACEUTICALS INC
0 catalysts
Marketed
vancomycin hydrochloride
Vancomycin Hydrochloride (vancomycin hydrochloride)
Bacterial Endocarditis
Samson Medical Technologies LLC
0 catalysts
Phase 2
vandefitemcel
vandefitemcel [INN]
Traumatic Brain Injury
SanBio Co Ltd
0 catalysts
Phase 2
vanoglipel
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
$MTVAMetaVia Inc.
0 catalysts
Phase 2
vardenafil hydrochloride
Vardenafil Hydrochloride (vardenafil hydrochloride)
Pulmonary Arterial Hypertension
cGMP-specific 3',5'-cyclic phosphodiesterase
Respira Therapeutics Inc
0 catalysts